Targovax ASA
Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a … Read more
Targovax ASA (0RIS) - Total Assets
Latest total assets as of June 2021: Nkr459.35 Million NOK
Based on the latest financial reports, Targovax ASA (0RIS) holds total assets worth Nkr459.35 Million NOK as of June 2021.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Targovax ASA - Total Assets Trend (2017–2020)
This chart illustrates how Targovax ASA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Targovax ASA - Asset Composition Analysis
Current Asset Composition (December 2020)
Targovax ASA's total assets of Nkr459.35 Million consist of 24.4% current assets and 75.6% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr0.00 | 22.9% |
| Accounts Receivable | Nkr3.64 Million | 0.7% |
| Inventory | Nkr0.00 | 0.0% |
| Property, Plant & Equipment | Nkr3.91 Million | 0.8% |
| Intangible Assets | Nkr389.65 Million | 74.8% |
| Goodwill | Nkr0.00 | 0.0% |
Asset Composition Trend (2017–2020)
This chart illustrates how Targovax ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Targovax ASA's current assets represent 24.4% of total assets in 2020, a decrease from 42.9% in 2017.
- Cash Position: Cash and equivalents constituted 22.9% of total assets in 2020, down from 40.6% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 74.0% of total assets, an increase from 56.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 74.8% of total assets.
Targovax ASA Competitors by Total Assets
Key competitors of Targovax ASA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
Targovax ASA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Targovax ASA generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Targovax ASA is currently not profitable relative to its asset base.
Targovax ASA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.85 | 2.27 | 2.86 |
| Quick Ratio | 2.85 | 2.27 | 2.86 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Nkr72.62 Million | Nkr 34.38 Million | Nkr 74.69 Million |
Targovax ASA - Advanced Valuation Insights
This section examines the relationship between Targovax ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 14.0% |
| Total Assets | Nkr520.74 Million |
| Market Capitalization | $16.43 Million USD |
Valuation Analysis
Below Book Valuation: The market values Targovax ASA's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Targovax ASA's assets grew by 14.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Targovax ASA (2017–2020)
The table below shows the annual total assets of Targovax ASA from 2017 to 2020.
| Year | Total Assets | Change |
|---|---|---|
| 2020-12-31 | Nkr520.74 Million | +13.97% |
| 2019-12-31 | Nkr456.91 Million | -15.02% |
| 2018-12-31 | Nkr537.64 Million | -16.47% |
| 2017-12-31 | Nkr643.61 Million | -- |